People with type 1 diabetes who depend on human insulin made by Novo Nordisk will instead be given glass vials and syringes - said to be inconvenient and harder to use with the same precision. Novo Nordisk has already stopped supply in South Africa, where patients have had to switch to glass vials. Novo Nordisk's decision is linked to its favoring of the marketing of the slimming drugs Ozempic and Wegovy.
Sources
O companie farmaceutică ar fi oprit producţia de seringi cu insulină pentru a vinde produse de slăbit
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk, compania producătoare de medicamente folosite pentru pierderea în greutate, acuzată că prioritizează profiturile după oprirea producției de stilouri cu insulină
Latest News
22:58
The Oradea City Hall will turn on the public lighting an hour later to reduce energy consumption.
22:42
Volodymyr Zelensky dismissed Olha Stefanișena from the position of ambassador to the USA, in the context of allegations of embezzlement.
22:30
Switzerland: An outbreak of legionellosis in Basel has led to 26 cases / Authorities suspect cooling towers as the source of contamination
22:18
Unit 2 of the Cernavodă Nuclear Power Plant can operate for only five days due to the decrease in the Danube's water level.
21:57
At Mița, the cyclist turns off the architectural lighting of the facade to reduce energy consumption.
See more news